Literature DB >> 21513704

Estrogen-related receptor ERRα-mediated downregulation of human hydroxysteroid sulfotransferase (SULT2A1) in Hep G2 cells.

Chaoqun Huang1, Tianyan Zhou, Yue Chen, Teng Sun, Shufen Zhang, Guangping Chen.   

Abstract

Hydroxysteroid sulfotransferase SULT2A1 catalyzes the sulfation of hydroxysteroids and xenobiotics. It plays an important role in the detoxification of hydroxyl-containing xenobiotics and in the regulation of the biological activities of hydroxysteroids. ERRα is an orphan member of the nuclear receptor superfamily that is closely related to estrogen receptor alpha (ERα). Here we report that the mRNA expression of human SULT2A1 was suppressed by ERRα in Hep G2 cells. To investigate the mechanisms of this regulation, the effects of ERRα on human SULT2A1 promoter transcription in Hep G2 cells were investigated. Reporter luciferase assay results showed that ERRα significantly represses human SULT2A1 promoter transcription in Hep G2 cells. Deletion analysis indicated that human SULT2A1 promoter region between positions -188 and -130 is necessary for its repression by ERRα in Hep G2 cells. The 5' DNA -188 to -130 region of human SULT2A1 contains IR2 and DR4 hormone response elements and two putative ERRα response elements (ERREs) (ERRE188: GCAAGCTCA and ERRE155: ATAAGTTCA). Interestingly, ERRE188 overlaps with the IR2 element and ERRE155 overlaps with the DR4 element. Our further investigation demonstrated that ERRα represses human SULT2A1 promoter transcription by competing with other nuclear receptors for binding to IR2 or DR4 elements. The interaction of ERRE188 and ERRE155 elements with ERRα was confirmed by electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) analysis. Our results suggest that ERRα may play an important role in regulating the metabolism of drugs and xenobiotics and in regulating endogenous hydroxysteroid activities via the regulation of SULT2A1.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21513704      PMCID: PMC3111048          DOI: 10.1016/j.cbi.2011.04.002

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  45 in total

1.  Molecular basis for the constitutive activity of estrogen-related receptor alpha-1.

Authors:  S Chen; D Zhou; C Yang; M Sherman
Journal:  J Biol Chem       Date:  2001-05-16       Impact factor: 5.157

2.  Estrogen-related receptor alpha 1 up-regulates endothelial nitric oxide synthase expression.

Authors:  Daigo Sumi; Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

3.  Estrogen-related receptor alpha 1 actively antagonizes estrogen receptor-regulated transcription in MCF-7 mammary cells.

Authors:  Richard J Kraus; Eric A Ariazi; Michael L Farrell; Janet E Mertz
Journal:  J Biol Chem       Date:  2002-05-01       Impact factor: 5.157

4.  Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer.

Authors:  Eric A Ariazi; Gary M Clark; Janet E Mertz
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

5.  Human sulfotransferase SULT2A1 pharmacogenetics: genotype-to-phenotype studies.

Authors:  B A Thomae; B W Eckloff; R R Freimuth; E D Wieben; R M Weinshilboum
Journal:  Pharmacogenomics J       Date:  2002       Impact factor: 3.550

6.  Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response.

Authors:  Min Sun Kim; Judy Shigenaga; Art Moser; Carl Grunfeld; Kenneth R Feingold
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-06-15       Impact factor: 4.310

7.  Estrogen receptor alpha and estrogen receptor-related receptor alpha1 compete for binding and coactivator.

Authors:  Z Zhang; C T Teng
Journal:  Mol Cell Endocrinol       Date:  2001-02-14       Impact factor: 4.102

8.  Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.

Authors:  Takashi Suzuki; Yasuhiro Miki; Takuya Moriya; Norihiro Shimada; Takanori Ishida; Hisashi Hirakawa; Noriaki Ohuchi; Hironobu Sasano
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

9.  Positive and negative regulation of human hepatic hydroxysteroid sulfotransferase (SULT2A1) gene transcription by rifampicin: roles of hepatocyte nuclear factor 4alpha and pregnane X receptor.

Authors:  Hai-Lin Fang; Stephen C Strom; Ewa Ellis; Zhengbo Duanmu; Jiaqi Fu; Zofia Duniec-Dmuchowski; Charles N Falany; Josie L Falany; Thomas A Kocarek; Melissa Runge-Morris
Journal:  J Pharmacol Exp Ther       Date:  2007-08-08       Impact factor: 4.030

10.  Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity.

Authors:  Hirotaka Kitada; Masaaki Miyata; Toshifumi Nakamura; Aki Tozawa; Wataru Honma; Miki Shimada; Kiyoshi Nagata; Christopher J Sinal; Grace L Guo; Frank J Gonzalez; Yasushi Yamazoe
Journal:  J Biol Chem       Date:  2003-03-07       Impact factor: 5.157

View more
  3 in total

Review 1.  Regulation of the cytosolic sulfotransferases by nuclear receptors.

Authors:  Melissa Runge-Morris; Thomas A Kocarek; Charles N Falany
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

2.  Dopamine D1 receptor activation induces dehydroepiandrosterone sulfotransferase (SULT2A1) in HepG2 cells.

Authors:  Jiao-Jiao Xu; Si-Yuan Wang; Ye Chen; Guang-Ping Chen; Zai-Quan Li; Xue-Yan Shao; Liang Li; Wei Lu; Tian-Yan Zhou
Journal:  Acta Pharmacol Sin       Date:  2014-06-09       Impact factor: 6.150

3.  Liver X receptor alpha mediated genistein induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1) in Hep G2 cells.

Authors:  Yue Chen; Shunfen Zhang; Tianyan Zhou; Chaoqun Huang; Alicia McLaughlin; Guangping Chen
Journal:  Toxicol Appl Pharmacol       Date:  2013-01-23       Impact factor: 4.219

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.